Authors: Olsson, B Brynne, N Johansson, C Arnberg, H

Citation: B. Olsson et al., Food increases the bioavailability of tolterodine but not effective exposure, J CLIN PHAR, 41(3), 2001, pp. 298-304

Authors: Brynne, N Svanstrom, C Aberg-Wistedt, A Hallen, B Bertilsson, L

Citation: N. Brynne et al., Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance, BR J CL PH, 48(4), 1999, pp. 553-563

Authors: Brynne, N Forslund, C Hallen, B Gustafsson, LL Bertilsson, L

Citation: N. Brynne et al., Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity, BR J CL PH, 48(4), 1999, pp. 564-572

Authors: Brynne, N Bottiger, Y Hallen, B Bertilsson, L

Citation: N. Brynne et al., Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole, BR J CL PH, 47(2), 1999, pp. 145-150